OSSIAN MEDICAL SOLUTIONS LTD.
- · Thesis: well-run, low negotiation leverage
Opportunity 73/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £13.7k | £12.1k |
| Cash | £15.8k | £16.7k |
| Net assets | £13.7k | £12.1k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (22 events)Click to expand
- 2025-11-18📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-11-15📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-08-17📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-07-13📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-06-04📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-08-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-09-05📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-12-17📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-11-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2016-11-08📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-03-29📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-07-14📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-03-26📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-11-03📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2014-03-26📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2012-03-26🏢Company incorporatedAs OSSIAN MEDICAL SOLUTIONS LTD.
- 2012-03-26➕CORFIELD, Alasdair Ross, Dr appointeddirector
- 2012-03-26➕HEARNS, Stephen, Dr appointeddirector
- 2012-03-26➕BRIAN REID LTD. appointedcorporate-secretary
- 2012-03-26➖BRIAN REID LTD. resignedcorporate-secretary
- 2012-03-26➕MABBOTT, Stephen George appointeddirector
- 2012-03-26➖MABBOTT, Stephen George resigneddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- secondary12+ year tenure: Director in role 14 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Stephen Thomas Hearns Individual · British · DOB 03/1970 · age 56 | 25–50% | — | 25-50% shares | 06/04/2016 |
Dr Alasdair Ross Corfield Individual · British · DOB 08/1972 · age 54 | 25–50% | — | 25-50% shares | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| MYK99 LIMITED→ SC870270 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| N.H. EYECARE LTD→ SC560356 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| NUNNMED LTD.→ SC701444 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| OLIVE FOUNTAIN ACADEMY LTD→ SC499971 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| OM CAREHOME LTD→ SC820982 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| OMAIR PHARMA LTD→ SC763276 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| OPTICAL EXPRESS (WESTFIELD) LIMITED→ SC161695 · est 1995 · no financials extracted | — | — | — | — | 30y | — | — |
| OUTREACH EYE CLINIC LTD→ SC344402 · est 2008 · no financials extracted | — | — | — | — | 17y | — | — |
| PARKSIDE AESTHETICS LIMITED→ SC673735 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| PC AESTHETICS & SKINCARE LTD→ SC849497 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| PLANNING FOR CARE LIMITED→ SC408508 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| PLATINUM PT LTD→ SC657411 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 2 resigned)
Click a director name to see their full track record across all companies.